BioMarin Pharmaceutical, Inc. (BMRN)

64.08 +0.66 (+1.04%) USD  |  NASDAQ  |  Feb 20, 16:00
64.00 -0.08 (-0.12%) After-Hours: 20:00
More

BioMarin Pharmaceutical Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade